In February 2022, Cochrane's Governing Board approved the proposed change to Cochrane’s evidence synthesis production model. We know this is a profound shift, leading to all kinds of questions, and new ideas right across the Cochrane community.
Our key focus since March 2022 has been to deliver more detailed plans about the model, begin implementing those plans, and share this information and address questions along the way.
A series of Future of Evidence Synthesis Programme webinars has been underway since April 2022, some focusing on individual projects and other addressing the questions and concerns of specific Cochrane groups, including Geographic Groups, Fields, Review Groups, Methods Groups and Consumers. The webinars ran on a fortnightly cycle initially, but from October will run monthly.
Cochrane Q&A: Changes ahead and what they mean for Cochrane Review Groups
Colleagues working in Review Groups are encouraged to attend this online Q&A session. It is a chance to ask the Project Team any questions you may have about the planned changes ahead and the whole session will be given over to questions. Please note: this session is for those working in Review Groups only, to ensure that we can answer as many questions from that group as possible.
- Date and time to be announced
Catch up on any sessions you may have missed by viewing them on the dedicated Future of Cochrane miro website.